Date: February 1, 2024
Attention: Providers
Effective date: Immediately
Call to action: On January 24, 2024, Azurity Pharmaceuticals voluntarily recalled one (1) lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg due to mislabeled packaging.
| Product | NDC No. | Lot No. | Exp. Date | Ship Dates to Wholesalers |
| Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg | 24338-856-03 | F230169A | 2025-06 | 08/23/2023 – 11/29/2023 |
How this impacts providers: Patients who received this medication within the ship dates of 8/23/23-11/29/23 are required to return the medication and receive a replacement.
Next step for Providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.
If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.
For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.